Lonza EasyDiff supplements for bone marrow CD34+

Friday, 22 July, 2011 | Supplied by: Capsugel Australia Pty Ltd

Lonza EasyDiff supplements for bone marrow CD34+

Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.

Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.

There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.

The supplements are suitable for both drug discovery and toxicology research.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

GeneTex carrier-free antibodies

GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...

Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set

The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...

Antibodies.com neutrophil marker antibodies

Antibodies.com offers a variety of markers that identify neutrophils at various stages of...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd